Synopsis:- Stocks remained in focus after multiple bulk deals, including stake sales of 0.8%, 5.53%, and 0.51%. Despite heavy selling, institutional buying supported sentiment. Meanwhile, indices gained with Sensex up 508 points and Nifty rising 138 points, reflecting broader market strength.
A bulk deal is a significant share transaction on the stock exchange, usually involving at least 0.5% of a company’s equity. Executed during trading hours and publicly disclosed, these deals help track investor sentiment, institutional participation, and potential changes in ownership structure.
The Sensex was up 508.17 points or 0.65 percent at 79,028.47, and the Nifty was up 138.15 points or 0.57 percent at 24,503.00. About 2438 shares advanced, 937 shares declined, and 151 shares were unchanged.
Ind-Swift Laboratories
Ind-Swift Laboratories Ltd operates in the pharmaceutical and biotechnology space, focusing on active pharmaceutical ingredients (APIs) and formulations. With a presence in global markets, the company emphasises research, manufacturing efficiency, and regulatory compliance, positioning itself to benefit from growing demand in the healthcare and generics industry.
With a market capitalisation of Rs 1,236.94 crore, the shares were trading at Rs 142.65 crore, increasing around 6.06 percent as compared to the previous closing price.
As per the exchange, HCP Investments offloaded 7 lakh shares, representing a 0.8% stake in Ind-Swift Laboratories Ltd, via a bulk deal on the BSE. The transaction was executed at ₹131.14 per share, totalling ₹9.17 crore, indicating a partial stake sale and potential portfolio rebalancing by the investor.
Earlier, as per the exchange, HCP Investments sold 48 lakh shares (5.53% stake) in Ind-Swift Laboratories Ltd at ₹134.18 per share, totalling ₹64.4 crore, after a prior 1.12% sale. This takes total divestment to 6.65% in two sessions, significantly reducing its holding from 8.65%, indicating a strategic exit or portfolio reshuffling.
However, as per the exchange, the selling pressure was partly absorbed by institutional buyers. Sahastraa Advisors acquired 4.75 lakh shares at ₹131.74, while Nova Global Opportunities Fund PCC – Touchstone picked up 8.03 lakh shares at ₹138.07. This balanced demand suggests continued investor interest despite the sharp stake reduction.
HEG
HEG Ltd is a leading Indian manufacturer of graphite electrodes, primarily used in steel production through electric arc furnaces. Part of the LNJ Bhilwara Group, the company has a strong global presence, exporting a significant portion of its output while benefiting from cyclical demand in the steel industry.
With a market capitalisation of Rs 12,642.92 crore, the shares were trading at Rs 654.65 crore, increasing around 3.91 percent as compared to the previous closing price.
As per the exchange, GDN Ventures sold 10 lakh shares, representing a 0.51% stake, in HEG Ltd at ₹631.02 per share, amounting to ₹63.1 crore. The transaction indicates partial stake dilution, likely reflecting profit booking or portfolio rebalancing amid prevailing market conditions.
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
The post Bulk Deals: 2 Stocks Where Investors Bought and Sold Stakes appeared first on Trade Brains.